Literature DB >> 17443332

[Treatment of pseudophakic cystoid macular edema].

H T Agostini1, L L Hansen, N Feltgen.   

Abstract

Pseudophakic cystoid macular edema (PCME) is the most common complication following cataract surgery. In 1-3% of cases it is associated with a decrease in visual acuity. However, PCME has a good prognosis, persisting in only 10% of the patients beyond 2 years. The prophylactic therapy of eyes without additional disease with non-steroidal antiphlogistic drugs or steroids does not influence the final visual acuity. Under certain circumstances, prophylaxis can be a reasonable option. Risk factors that promote the formation of PCME are discussed. The course of acute or chronic PCME can be influenced by drug treatment, but in general the level of evidence for the treatment of this widespread problem is low. We would therefore like to present the Freiburg treatment scheme for PCME for discussion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17443332     DOI: 10.1007/s00347-007-1534-9

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  46 in total

1.  Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide.

Authors:  Jost B Jonas; Ingrid Kreissig; Robert Degenring
Journal:  Arch Ophthalmol       Date:  2003-05

2.  Retained intravitreal lens fragments after phacoemulsification: complications and visual outcome in vitrectomized and nonvitrectomized eyes.

Authors:  Alberto Rossetti; Daniele Doro
Journal:  J Cataract Refract Surg       Date:  2002-02       Impact factor: 3.351

3.  Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema.

Authors:  John O Mason; Michael A Albert; Rachel Vail
Journal:  Retina       Date:  2006-03       Impact factor: 4.256

4.  Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine.

Authors:  A J Flach; L M Jampol; D Weinberg; M C Kraff; L A Yannuzzi; R V Campo; A C Neumann; H P Cupples; W H Lefler; J S Pulido
Journal:  Am J Ophthalmol       Date:  1991-11-15       Impact factor: 5.258

5.  Ineffectiveness of indomethacin in the treatment of chronic cystoid macular edema.

Authors:  L A Yannuzzi; R M Klein; R H Wallyn; N Cohen; I Katiz
Journal:  Am J Ophthalmol       Date:  1977-10       Impact factor: 5.258

6.  Efficacy of topical flurbiprofen and indomethacin in preventing pseudophakic cystoid macular edema. Flurbiprofen-CME Study Group I.

Authors:  L D Solomon
Journal:  J Cataract Refract Surg       Date:  1995-01       Impact factor: 3.351

7.  Intravitreal bevacizumab for treatment of uveitic macular edema.

Authors:  Miguel Cordero Coma; Lucia Sobrin; Sumru Onal; William Christen; C Stephen Foster
Journal:  Ophthalmology       Date:  2007-03-23       Impact factor: 12.079

8.  Retinal phlebitis in the Irvine-Gass syndrome.

Authors:  N F Martin; W R Green; L W Martin
Journal:  Am J Ophthalmol       Date:  1977-03       Impact factor: 5.258

9.  Pseudophakic cystoid maculopathy: a study of 50 cases.

Authors:  A L Stern; D M Taylor; L A Dalburg; R T Cosentino
Journal:  Ophthalmology       Date:  1981-09       Impact factor: 12.079

10.  Reduction of macular oedema by acetazolamide in patients with chronic iridocyclitis: a randomised prospective crossover study.

Authors:  M D Farber; S Lam; H H Tessler; T J Jennings; A Cross; M M Rusin
Journal:  Br J Ophthalmol       Date:  1994-01       Impact factor: 4.638

View more
  1 in total

1.  [Cataract surgery. Effect on the posterior segment of the eye].

Authors:  W A Herrmann; H Heimann; H Helbig
Journal:  Ophthalmologe       Date:  2010-10       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.